Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Circulation Galiè et al.
117: 3010
Data Supplement
Files in this Data Supplement:
- Figure I
-
(Microsoft PowerPoint file) (54 KB). Flow diagram of patients enrolled in the ARIES-1 trial and in the long-term extension study who underwent screening and randomization.
- Figure II
-
(Microsoft PowerPoint file) (52 KB). Flow diagram of patients enrolled in the ARIES-2 trial and in the long-term extension study who underwent screening and randomization.
